Live Breaking News & Updates on Precise Tumor|Page 2

Stay updated with breaking news from Precise tumor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Myriad Genetics Inc (MYGN) Reports 11% Revenue Growth in Q4 and Full-Year 2023

Company Raises 2024 Revenue Guidance and Delivers Positive Adjusted EPS in Q4 ....

Bracanalysis Cdx , Paulj Diaz , Genetics Inc , Diagnostics Research , Analysis Of Company Performance , Company Overview , Precise Oncology Solutions , Intermountain Precision Genomics , Myriad Genetics , Medical Diagnostics , Myriad Genetic , Foresight Universal Plus , Precise Tumor , Myriad Genetics Inc , Intermountain Precision Genomics , Operating Expenses , Revenue Growth , Precision Medicine , Revenue Guidance , Testing Services , Prenatal Testing ,

Myriad Genetics Completes Acquisition of Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics

SALT LAKE CITY, Feb. 01, 2024 Myriad Genetics, Inc., , a leader in genetic testing and precision medicine, today announced it has completed the acquisition from Intermountain Health of select. ....

United States , Glenn Farrell , Matt Scalo , Intermountain Health , Exchange Commission , Genetics Inc , Globenewswire Inc , Intermountain Precision Genomics , Tumor Test , Precise Liquid Test , Precise Tumor Test , Solid Tumor , Precise Tumor , Precise Liquid , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Current Reports ,

Myriad Genetics Completes Acquisition of Precise Tumor,

SALT LAKE CITY, Feb. 01, 2024 (GLOBE NEWSWIRE) Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today. ....

United States , Matt Scalo , Glenn Farrell , Intermountain Health , Exchange Commission , Genetics Inc , Intermountain Precision Genomics , Tumor Test , Precise Liquid Test , Precise Tumor Test , Solid Tumor , Precise Tumor , Precise Liquid , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Current Reports , Nasdaq Mygn , Myriad Genetics ,

Myriad Genetics (MYGN) to Acquire Precise Tumor, Precise Liquid and Laboratory

Myriad Genetics (MYGN) to Acquire Precise Tumor, Precise Liquid and Laboratory
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Paulj Diaz , Genetics Inc , Intermountain Health System , Myriad Genetics , Intermountain Precision Genomic , Tumor Test , Precise Liquid Test , Precise Tumor Test , Precise Tumor , Precise Liquid , Intermountain Healthcare , Solid Tumor ,

Myriad Genetics to Acquire Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics - Myriad Genetics (NASDAQ:MYGN)

SALT LAKE CITY, Jan. 18, 2024 (GLOBE NEWSWIRE) Myriad Genetics, Inc., (NASDAQ:MYGN), a leader in genetic testing and precision medicine, today announced it has entered into a definitive agreement to acquire select ....

United States , Glenn Farrell , Paulj Diaz , Matt Scalo , Intermountain Health System , Exchange Commission , Genetics Inc , Intermountain Precision Genomic , Tumor Test , Precise Liquid Test , Precise Tumor Test , Precise Tumor , Precise Liquid , Intermountain Healthcare , Solid Tumor , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Current Reports ,